Astressin-B is a chemical compound that blocks certain hormones that are known to cause increased stress. It was developed by Salk Institute for Biological Studies in La Jolla, California for research in CRF signaling pathways. Following their study, a team from UCLA began research on stress and hormone relationships in brain-gut disorders using mice that had been genetically altered to create the CRF factor more rapidly. In their tests, they used Salk’s compound to monitor any effects. To their amazement, the mice that had gone totally bald on their backs had regrown all their hair in a matter of months. With that the announcement of Astressin-B as a potential hair regrowth treatment hit the scientific journals around the world.
Thus far, the injection treatment has only been tested on lab mice. That is an important distinction to remember. The FDA admits that approval for actual human testing for the purpose of using this compound as a hair loss and regrowth product may be 5 to 10 years away.
It was these same researchers at UCLA that discovered the effects of antihypertensive medications on mice prior to its approval by the FDA. If the rate of growth detected in mice during the earlier study and in humans holds true, the preliminary results of Astressin-B in mice could signal a huge break through in the treatment for hair loss in women and men.
What interested the scientists most was how few treatments for hair loss and regrowth were needed and how long the treatments lasted. They injected mice with the chemical compound once a day for five days. They set them aside for three months speculating that this would be sufficient time to notice any change in the brain-gut interaction and what changes may have taken place. This is when they discovered that the bald mice had regrown all their hair. Additionally, the treatment was not needed again for four months.
There are currently topical creams on the market that have Astressin-B included in their ingredients. It has come to the attention of some medical specialists and the researchers, that some people are injecting these topical medications. The researchers have issued repeated warnings that these creams and ointments contain other chemical compounds that are designed to interact as a topical application. When hair products are not used as directed, they may be dangerous.
The research on Astressin-B is encouraging for all those with stress related hair loss and regrowth hopes. This blocker is not a stem cell product. This means that approval from the FDA may arrive more quickly since the hoops are not so many.



Leave A Reply (No comments So Far)
The comments are closed.
No comments yet